Skip to main content
. 2018 Sep 17;9(10):1045–1050. doi: 10.1021/acsmedchemlett.8b00352

Table 1. Inhibition Data toward hCA I, II, IX, XII, and hCOX 1 and 2 Isozymes of Compounds EMAC10111a–g.

graphic file with name ml-2018-00352w_0005.jpg

  Ki(μM)
IC50 (μM)
Compound EMAC R hCA I hCA II hCA IX hCA XII hCOX-1 hCOX-2
10111a 4-Cl 0.49 0.28 1.25 0.65 * 16.21
10111b 2,4-Cl 0.75 0.053 2.78 0.34 * 18.32
10111c 4-Br 3.46 0.32 2.44 0.80 * 19.73
10111d 4-CH3 0.96 0.26 2.26 0.78 * *
10111le 4-OCH3 3.37 0.28 2.25 0.84 * 21.78
10111f H 8.02 3.10 3.54 0.30 * *
10111g // 9.07 0.86 3.43 0.06 * 12.61
Reference compounds
AAZ / 0.25 0.01 0.02 0.006 / /
Indomethacin / / / / / 12.16 35.20
Diclofenac / / / / / 18.23 23.62
FR122047 / / / / / 0.09 **
Nimesulide / / / / / *** 23.14
DuP 697 / / / / / 22.61 0.12
*

Inactive at 25 μM (highest concentration tested). At higher concentrations, the compounds precipitate.

**

Inactive at 100 μM (highest concentration tested). At higher concentrations, the compound precipitates.

***

Inactive at 500 μM (highest concentration tested). At higher concentrations, the compound precipitates.